Oct 25, 2022
In this week’s episode, GOLD speaks to Patrick Short, CEO, Sano Genetics, about the challenges and opportunities in genetic medicine today. He discusses his personal connection to tackling genetic diseases, the top reasons behind research participation hesitancy and the therapy areas in which he believes genomic...
Oct 18, 2022
In this week’s episode, Helena and Isabel share an interview with GOLD’s next Catalyst Reshema Kemps-Polanco, Executive Vice President and US Head, Novartis Oncology. In this special extended version of the interview exclusive to the podcast, hear Reshema’s story and insights in full, including the...
Oct 11, 2022
In this week’s episode, Helena is joined by Paul Simms, CEO of Impatient Health, to delve deeper into GOLD’s recent cover feature on reframing pharma’s bad boy reputation. They chat about the current state of pharma’s reputation and the influence of the media and pop culture on this, the ways in which pharma can...
Oct 4, 2022
In this week's episode Helena and Isabel were honoured to be joined by Rino Rappuoli, Head of External R&D and Chief Scientist at GSK Vaccines. He discusses his career inspiration and journey; his work on novel scientific concepts such as reverse vaccinology, which modern vaccines are based on; and his interest in...